About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
351
By Phase
PHASE1: 3PHASE2: 3
By Status
COMPLETED: 3WITHDRAWN: 2TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT04835168Lead Sponsor
Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis
PHASE1Withdrawn
Started: Jan 30, 2022 · Completed: Jun 30, 2022
NCT05057273Lead Sponsor
Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease
PHASE2Withdrawn
Started: Nov 30, 2021 · Completed: Feb 28, 2022
NCT05019950Lead Sponsor
Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers
PHASE1Completed
56 participants
Started: Oct 28, 2021 · Completed: Apr 28, 2022
NCT03870334Lead Sponsor
Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease
PHASE2Terminated
27 participants
Started: May 5, 2021 · Completed: Aug 26, 2022
NCT03861143Lead Sponsor
Efficacy and Safety of Oral BT-11 in Ulcerative Colitis
PHASE2Completed
198 participants
Started: Aug 14, 2019 · Completed: Jun 17, 2021
Locations (1)
Headquarters
Blacksburg, VA, United States
Map
Loading map...